The effect of anesthesia type on needle localization breast biopsy: Another point of view

Papa, Moshe Z.; Klein, Ehud; Davidson, Benny; Karni, Tami; Sperber, Fani; Koller, Moshe; Ravid, M; Ari, Gur Ben

doi:10.1016/s0002-9610(97)89558-x

Cited by 29 publications

(14 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a previous work [14], we have shown that the type of anesthesia affects the rate of positive margins found at pathological examination of the biopsy specimen. The type of anesthesia also correlated with the size of specimen excised.…”

Section: Discussionmentioning

confidence: 90%

Positive margins of breast biopsy: Is reexcision always necessary?

et al. 1999

Self Cite

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 90%

Positive margins of breast biopsy: Is reexcision always necessary?

et al. 1999

Self Cite

View full text Add to dashboard Cite

“…7 All patients were anaesthetized according to the protocol used in our institution. Patients were premedicated with 5 mg oral Diazepam.…”

Section: Methodsmentioning

confidence: 99%

Pre-operative cardiac workup after anthracycline-based neoadjuvant chemotherapy. Is it really necessary?

Shapiro

Barsuk

Segev

et al. 2011

annals

View full text Add to dashboard Cite

INTRODUCTION In patients receiving pre-operative anthracyclines for locally advanced breast cancer, early cardiotoxicity is a well-recognised complication that may interfere with surgery. The aim of this study was to assess the safety of breast surgery after neoadjuvant treatment with Doxorubicin. PATIENTS AND METHODS A retrospective study of breast cancer patients treated with Doxorubicin as part of their neoadjuvant protocol. All patients were subsequently operated in our institution. Intra-operative and postoperative haemodynamic, cardiac or respiratory events were collected. RESULTS A total of 83 patients were included. All patients had a normal left ventricular ejection fraction before starting on chemotherapy. Doxorubicin was given in conjunction with Cyclophosphamide and Paclitaxel. The cumulative dose of Doxorubicin was 240 mg/m 2 . All patients completed their chemotherapy less than a year before surgery and were clinically asymptomatic. Of the patients, 2.3% displayed a significant reduction in cardiac function to meet cardiotoxicity criteria, although not clinically apparent. No complications occurred intra-operatively or postoperatively. CONCLUSIONS Breast surgery can be safely performed after breast neoadjuvant chemotherapy with Doxorubicin. The risk of early cardiotoxicity does not mandate a cardiac function assessment after completion of treatment. Work-up should be individualised according to the anthracycline regimen, patient's cardiac risk factors and functional status before surgery.

show abstract

“…In non-palpable lesions, per operative FS is frequently used in planning single step surgical treatment, if sufficient tissue is (6,(7)(8)(9)(10)(11). Today, FS is used widely in BCS for diagnosis, evaluating tumor margin and for detecting metastasis in sentinel lymph biopsy (12).…”

Section: Discussion Discussionmentioning

confidence: 99%